| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |